LSE - Delayed Quote GBp

Spire Healthcare Group plc (SPI.L)

Compare
228.50
-0.50
(-0.22%)
At close: 4:35:28 PM GMT
Loading Chart for SPI.L
DELL
  • Previous Close 229.00
  • Open 228.50
  • Bid 228.50 x --
  • Ask 229.50 x --
  • Day's Range 228.50 - 230.50
  • 52 Week Range 212.50 - 321.71
  • Volume 628,496
  • Avg. Volume 383,190
  • Market Cap (intraday) 923.608M
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) 32.64
  • EPS (TTM) 0.07
  • Earnings Date Mar 6, 2025
  • Forward Dividend & Yield 0.03 (1.14%)
  • Ex-Dividend Date May 23, 2024
  • 1y Target Est 307.38

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers in-patient, daycase, and out-patient care services through hospitals and clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

www.spirehealthcare.com

12,787

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SPI.L

View More

Performance Overview: SPI.L

Trailing total returns as of 2/12/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

SPI.L
1.11%
FTSE 100
7.76%

1-Year Return

SPI.L
3.23%
FTSE 100
16.29%

3-Year Return

SPI.L
4.82%
FTSE 100
14.96%

5-Year Return

SPI.L
79.62%
FTSE 100
16.90%

Compare To: SPI.L

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SPI.L

View More

Valuation Measures

As of 2/11/2025
  • Market Cap

    921.60M

  • Enterprise Value

    2.13B

  • Trailing P/E

    33.68

  • Forward P/E

    15.50

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.66

  • Price/Book (mrq)

    1.25

  • Enterprise Value/Revenue

    1.47

  • Enterprise Value/EBITDA

    8.83

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.96%

  • Return on Assets (ttm)

    3.73%

  • Return on Equity (ttm)

    4.00%

  • Revenue (ttm)

    1.44B

  • Net Income Avi to Common (ttm)

    28.3M

  • Diluted EPS (ttm)

    0.07

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    46.1M

  • Total Debt/Equity (mrq)

    169.51%

  • Levered Free Cash Flow (ttm)

    55.59M

Research Analysis: SPI.L

View More

People Also Watch